Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Net Income towards Common Stockholders (2017 - 2025)

Catheter Precision (VTAK) has disclosed Net Income towards Common Stockholders for 9 consecutive years, with -$592000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 85.63% to -$592000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$24.2 million, a 107.37% decrease, with the full-year FY2024 number at -$21.8 million, up 69.45% from a year prior.
  • Net Income towards Common Stockholders was -$592000.0 for Q3 2025 at Catheter Precision, up from -$8.1 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $3.1 million in Q3 2021 to a low of -$67.2 million in Q1 2023.
  • A 5-year average of -$7.6 million and a median of -$4.8 million in 2022 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: soared 142.45% in 2021, then crashed 1512.26% in 2024.
  • Catheter Precision's Net Income towards Common Stockholders stood at -$8.3 million in 2021, then rose by 1.5% to -$8.2 million in 2022, then soared by 91.8% to -$669000.0 in 2023, then plummeted by 1512.26% to -$10.8 million in 2024, then skyrocketed by 94.51% to -$592000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Net Income towards Common Stockholders are -$592000.0 (Q3 2025), -$8.1 million (Q2 2025), and -$4.8 million (Q1 2025).